White Papers
Confirmation of Structural Variant Calls from Long-Read Sequencing
Are you leveraging the full potential of long-read sequencing (LRS) in your genomic research?
LRS has revolutionized the detection of structural variants (SVs), yet challenges remain, particularly in repetitive or complex DNA regions where false positives and unclear results are more common.
This white paper explores how Electronic Genome Mapping (EGM) on the OhmX™ Platform—pioneered by Nabsys—can act as a powerful orthogonal validation tool for SV detection. With the ability to analyze ultra-long DNA samples, EGM delivers unmatched accuracy in detecting SVs ranging from hundreds of base pairs to several hundred kilobases, even within complex or repetitive sequences.
Dive into our findings as we assess EGM's performance in verifying PacBio-reported SVs from the well-studied HG002 cell line.
Download Now
Please complete the form below to download the white paper.
Share This
Cancer Research
Gain deeper insights and drive breakthroughs in cancer research with the OhmX™ Platform, powered by electronic genome mapping (EGM) and expertly engineered to unravel the complexities of structural variants (SVs) in cancer genomes.
Orthogonal Validation of NGS and LRS
Gain confidence in your genomic discoveries from NGS and long-read sequencing (LRS) platforms with a low-cost solution to verify, clarify, and identify structural variant (SV) calls.
Rare Disease
Unravel complexities and gain critical insights with the OhmX™ Platform, designed to help you push the boundaries of rare disease research.
Cell and Gene Therapy
EGM provides clarity to genomic integrity where other tools can’t.